These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28704435)

  • 1. Generation of an artificial human B cell line test system using Transpo-mAbTM technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins.
    Klose D; Woitok M; Niesen J; Beerli RR; Grawunder U; Fischer R; Barth S; Fendel R; Nachreiner T
    PLoS One; 2017; 12(7):e0180305. PubMed ID: 28704435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen.
    Klose D; Saunders U; Barth S; Fischer R; Jacobi AM; Nachreiner T
    BMC Biotechnol; 2016 Feb; 16():18. PubMed ID: 26883813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granzyme M as a novel effector molecule for human cytolytic fusion proteins: CD64-specific cytotoxicity of Gm-H22(scFv) against leukemic cells.
    Schiffer S; Letzian S; Jost E; Mladenov R; Hristodorov D; Huhn M; Fischer R; Barth S; Thepen T
    Cancer Lett; 2013 Dec; 341(2):178-85. PubMed ID: 23973499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor.
    Niesen J; Hehmann-Titt G; Woitok M; Fendel R; Barth S; Fischer R; Stein C
    Cancer Lett; 2016 May; 374(2):229-40. PubMed ID: 26912070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted ex vivo reduction of CD64-positive monocytes in chronic myelomonocytic leukemia and acute myelomonocytic leukemia using human granzyme B-based cytolytic fusion proteins.
    Schiffer S; Rosinke R; Jost E; Hehmann-Titt G; Huhn M; Melmer G; Barth S; Thepen T
    Int J Cancer; 2014 Sep; 135(6):1497-508. PubMed ID: 24523193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
    Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
    Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of autoreactive B-lymphocytes by a recombinant myelin oligodendrocyte glycoprotein-based immunotoxin.
    Nachreiner T; Kampmeier F; Thepen T; Fischer R; Barth S; Stöcker M
    J Neuroimmunol; 2008 Mar; 195(1-2):28-35. PubMed ID: 18280586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface charge-modification prevents sequestration and enhances tumor-cell specificity of a recombinant granzyme B-TGFα fusion protein.
    Jabulowsky RA; Oberoi P; Bähr-Mahmud H; Dälken B; Wels WS
    Bioconjug Chem; 2012 Aug; 23(8):1567-76. PubMed ID: 22759275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies.
    Ten Haaf A; Pscherer S; Fries K; Barth S; Gattenlöhner S; Tur MK
    Immunol Lett; 2015 Aug; 166(2):65-78. PubMed ID: 26045318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated mouse B cells lack expression of granzyme B.
    Hagn M; Belz GT; Kallies A; Sutton VR; Thia KY; Tarlinton DM; Hawkins ED; Trapani JA
    J Immunol; 2012 Apr; 188(8):3886-92. PubMed ID: 22427643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partners.
    Tran M; Henry RE; Siefker D; Van C; Newkirk G; Kim J; Bui J; Mayfield SP
    Biotechnol Bioeng; 2013 Nov; 110(11):2826-35. PubMed ID: 23719862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression, purification and anticancer analysis of GST-tagged human perforin and granzyme B proteins in human laryngeal cancer Hep-2 cells.
    Li X; Zhang G; An G; Liu S; Lai Y
    Protein Expr Purif; 2014 Mar; 95():38-43. PubMed ID: 24291445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene cloning, optimized expression and immunogenicity evaluation of tetanus toxin fragment C].
    Wang MY; Zhang YN; Lei M; Zuo DM; Zhang LY; Chen ZL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):731-5. PubMed ID: 18504192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition.
    Dälken B; Giesübel U; Knauer SK; Wels WS
    Cell Death Differ; 2006 Apr; 13(4):576-85. PubMed ID: 16179940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
    Klimka A; Barth S; Matthey B; Roovers RC; Lemke H; Hansen H; Arends JW; Diehl V; Hoogenboom HR; Engert A
    Br J Cancer; 1999 Jun; 80(8):1214-22. PubMed ID: 10376974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific targeting and elimination of EBV-transformed B cells by allergen toxins.
    Stöcker M; Klockenbring T; Huhn M; Nachreiner T; Wicklein D; Petersen A; Bauer R; Goerlich R; Fischer R; Barth S
    J Allergy Clin Immunol; 2005 Oct; 116(4):910-5. PubMed ID: 16210069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human microtubule-associated protein tau mediates targeted killing of CD30(+) lymphoma cells in vitro and inhibits tumour growth in vivo.
    Hristodorov D; Nordlohne J; Mladenov R; Huhn M; Fischer R; Thepen T; Barth S
    Br J Haematol; 2014 Jan; 164(2):251-7. PubMed ID: 24164493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Granzyme B-VEGF receptor-binding peptide fusion protein expressed in B. longum induces apoptosis of KDR-positive cells].
    Chen L; Zeng W; Zheng H
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1059-63. PubMed ID: 22820600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of granzyme B-azurin fusion protein on breast cancer cells.
    Paydarnia N; Khoshtinat Nikkhoi S; Fakhravar A; Mehdiabdol M; Heydarzadeh H; Ranjbar S
    Mol Biol Rep; 2019 Jun; 46(3):3129-3140. PubMed ID: 30937652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-apoptotic effect of an anti-CD37 scFv-Fc fusion protein, in combination with the anti-CD20 antibody, ofatumumab, on tumour cells from B-cell malignancies.
    Smolewski P; Robak P; Cebula-Obrzut B; Misiewicz M; Mędra A; Majchrzak A; Witkowska M; Stromatt S; Robak T
    Eur J Cancer; 2014 Oct; 50(15):2677-84. PubMed ID: 25154027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.